Gain Therapeutics | ARS: Annual Report to Security Holders
Apr 26 16:35 ET
Gain Therapeutics | DEFA14A: Others
Apr 26 16:11 ET
Gain Therapeutics | DEF 14A: Definitive information statements
Apr 26 16:08 ET
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mack Gene
Apr 8 19:48 ET
Gain Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Mack Gene
Apr 8 19:43 ET
Gain Therapeutics | 8-K: Current report
Apr 8 16:28 ET
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Riley Jeffrey Scott
Apr 1 16:03 ET
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Alder Matthias
Mar 28 21:00 ET
Gain Therapeutics | 10-K: Annual report
Mar 26 16:12 ET
Gain Therapeutics | 8-K: Current report
Mar 26 16:06 ET
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fuggetta Gianluca
Mar 25 21:35 ET
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Alder Matthias
Mar 25 21:35 ET
Gain Therapeutics | 8-K: Current report
Feb 22 07:01 ET
Gain Therapeutics | 8-K: Current report
Jan 31 17:28 ET
Gain Therapeutics | 424B3: Prospectus
Jan 2 00:00 ET
Gain Therapeutics | EFFECT: Others
Jan 2 00:00 ET
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias
Dec 22, 2023 16:17 ET
Gain Therapeutics | CORRESP: CORRESP
Dec 22, 2023 12:28 ET
Gain Therapeutics | UPLOAD: Others
Dec 21, 2023 12:28 ET
Gain Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Dec 19, 2023 16:52 ET
No Data
No Data